The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index; none of the 31 sources its claims cite is checked for support yet.
High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment Options
Open accessAbstract
BACKGROUND: Empirical antibiotic therapy for nongonococcal urethritis (NGU) and cervicitis is aimed at Chlamydia trachomatis, but Mycoplasma genitalium, which also commonly causes undiagnosed NGU, necessitates treatment with macrolides or fluoroquinolones rather than doxycycline, the preferred chlamydia treatment. Prevalence of M. genitalium and associated genotypic markers of macrolide and fluoroquinolone resistance among men symptomatic of urethritis were investigated. Genetic diversity of M. genitalium populations was determined to infer whether findings were applicable beyond our setting. METHODS: Mycoplasma genitalium and other NGU pathogens were detected using nucleic acid amplification methods, and DNA sequencing was used to detect genotypic resistance markers of macrolide and fluoroquinolone antibiotics in 23S ribosomal RNA, gyrA, gyrB, and parC genes. MG191 single-nucleotide polymorphism typing and MG309 variable number tandem analysis were combined to assign a dual locus sequence type (DLST) to each positive sample. RESULTS: Among 217 men, M. genitalium prevalence was 16.7% (95% confidence interval [CI], 9.5%-24.0%) and C. trachomatis prevalence was 14.7% (95% CI, 7.8%-21.6%) in NGU cases. Nine of 22 (41%; 95% CI, 20%-62%) patients with M. genitalium were infected with DLSTs possessing genotypic macrolide resistance and 1 patient was infected with a DLST having genotypic fluoroquinolone resistance. Typing assigned M. genitalium DLSTs to 2 major clusters, broadly distributed among previously typed international strains. Genotypic macrolide resistance was spread within these 2 clusters. CONCLUSIONS: Mycoplasma genitalium is a frequent undiagnosed cause of NGU in this population with rates of macrolide resistance higher than those previously documented. Current guidelines for routine testing and empirical treatment of NGU should be modified to reduce treatment failure of NGU and the development of further resistance.
Overview
CoChat Summary
TL;DR
In this single-clinic observational study of 217 men with urethritis symptoms, *Mycoplasma genitalium* was detected in 16.7% of nongonococcal urethritis (NGU) cases, comparable to *Chlamydia trachomatis* (14.7%), and 41% of *M. genitalium* isolates had macrolide resistance markers. The authors conclude that routine *M. genitalium* testing and reappraisal of first-line NGU treatment are needed.
Key findings
- Among 102 NGU cases, *M. genitalium* prevalence was 17/102 (16.7%; 95% CI, 9.5%–24.0%), similar to *C. trachomatis* at 15/102 (14.7%; 95% CI, 7.8%–21.6%; *P* = .86 for Ct vs Mg). In men with no urethritis, *M. genitalium* was 5/107 (4.7%) and *C. trachomatis* was 2/107 (1.9%).
- Of 22 *M. genitalium*–positive samples, macrolide resistance markers were detected in 9 (41%; 95% CI, 20%–62%), and 1 sample (4.5%; 95% CI, 1%–21%) had a *parC* quinolone resistance–determining region mutation associated with fluoroquinolone resistance.
- Macrolide resistance markers were carried in 6/17 NGU cases and 3/5 no-urethritis cases; the paper reports no obvious clinical associations with antibiotic resistance.
- Typing showed 11/22 infections caused by 8 known MG191 sequence types and 11 novel types (A–J); phylogenetic analysis revealed two major clusters, both containing drug-resistant mutations (Major Cluster A: 7/12 resistant; Major Cluster B: 2/10 resistant).
Methods
- Observational study of all men prospectively presenting with urethritis symptoms to the Genitourinary Medicine Clinic at St George’s Hospital, Tooting, London, between 28 September and 15 December 2011; 217 men were recruited, including 18 men who have sex with men.
- Residual first-void urine samples were tested for *C. trachomatis* and *Neisseria gonorrhoeae* by NAAT and for *M. genitalium* and *Trichomonas vaginalis* by PCR; *M. genitalium*–positive extracts were tested for 23S rRNA macrolide resistance SNPs and *gyrA/gyrB/parC* QRDR SNPs, and typed by MG191 SNP and MG309 VNTR markers with phylogenetic analysis.
- Prevalence was compared using χ² and McNemar tests; clinical notes were reviewed at 3 months after presentation to assess treatment failure.
Limitations
- The paper states the study was limited by being based in a single clinic and conducted over a relatively short period; the authors addressed this by assessing *M. genitalium* genetic diversity with a dual-locus typing system.
- Evident from the text: only 22 *M. genitalium*–positive samples were available, so resistance prevalence estimates have wide confidence intervals.
- Evident from Table 2: many patients had no follow-up attendance, limiting assessment of treatment failure or persistence; the study also enrolled only men with urethritis symptoms, so findings may not directly generalize to women, cervicitis, or asymptomatic populations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
0 Valid · 0 Not valid · 17 Not checked · 27 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Macrolide resistance was detected in 9 samples (41%; [95% CI, 20%–62%]).”
- Also stated in: § DISCUSSION · plain
“In addition, >40% of M. genitalium infections had genotypic resistance to macrolide antibiotics, one of the recommended first-line options for NGU.”
- Also stated in: § Abstract · plain
“Mycoplasma genitalium infections were as frequent a cause of nongonococcal urethritis as Chlamydia trachomatis, had high rates of macrolide-associated genotypic resistance, and were nonclonal, suggesting an established community infection.”
§ High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment Options > RESULTS > Genotypic Resistance Markers
plainn = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § DISCUSSION · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Phylogenetic analysis revealed a tree of 18 DLSTs, divided clearly into 2 major clusters, which we designated Major Cluster A (MCA) and B (MCB) (Figure 1).”
§ High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment Options > RESULTS > Relatedness of M. genitalium
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There were no obvious clinical associations with antibiotic resistance.”
§ High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment Options > RESULTS > Genotypic Resistance Markers
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Eleven of 22 M. genitalium infections were caused by 8 STs identical to MG191 alleles in the literature [14–16], designated ST 2, 3, 4, 8, 21, 23, 24, and 44.”
§ High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment Options > RESULTS > Relatedness of M. genitalium
What the sources say
- Not checked yetcites [14] Cazanave C Charron A Renaudin H Bébéar C Method comparison for molecular typing of French and Tunisian Mycoplasma genitalium-positive specimens J Med Microbiol 2012 61 500 6 22160316
- Not checked yetcites [15] Hjorth SV Björnelius E Lidbrink P Sequence-based typing of Mycoplasma genitalium reveals sexual transmission Clin Microbiol 2006 44 2078 83 PMC1489459 16757601
- Not checked yetcites [16] Ma L Taylor S Jensen JS Myers L Lillis R Martin DH Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system BMC Microbiol 2008 8 130 18664269 PMC2515158
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“P value, Ct vs Mgb | | 1 | | .86 | | |”
§ High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment Options > RESULTS > Prevalence of Infection
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
12 more claims
Create a free account to see all 44 claims and to verify the 31 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 9
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment Options > RESULTS > Relatedness of M. genitalium
“We therefore assigned the 4 sequence types, in which MG-309-STR had failed, to these major clusters accordingly (Table 2).”
§ High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment Options > RESULTS > Genotypic Resistance Markers
“| 219 | MSW | NGU-HSV | Doxycycline | ND | Nil | I | 10 | WT | WT | A | | | 189 | MSW | NGU | Doxycycline | None | Nil | H | Nontypeable | WT | WT | A | | | 43 | MSW | NGU | Doxycycline | ND | Nil | 3 | 15 | A2058G | WT | A | A | | 22 | MSW | NGU | Doxycycline | Doxycycline | 1 mog | B | 13 | WT | WT | A | |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment Options > RESULTS > Genotypic Resistance Markers
“none of the 6 cases with NGU and macrolide resistance, 2 of whom were treated with doxycycline and 4 with single-dose azithromycin”
§ High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment Options > RESULTS > Genotypic Resistance Markers
“| 43 | MSW | NGU | Doxycycline | ND | Nil | 3 | 15 | A2058G | WT | A | A |”
Citations
Cites
RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models
Stamatakis, A. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl446 · Cited by 15,582
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A., & Berman, S. M. (2007) · Clinical Infectious Diseases · doi:10.1086/511430 · Cited by 1,973
Sexually Transmitted Diseases 7982 Treatment Guidelines
(1982) · American Pharmacy · doi:10.1016/s0160-3450(16)31823-2 · Cited by 1,573
Jensen, J. S., Bradshaw, C. S., Tabrizi, S. N., Fairley, C. K., & Hamasuna, R. (2008) · Clinical Infectious Diseases · doi:10.1086/593188 · Cited by 338
Jensen, J. S., Björnelius, E., Dohn, B., & Lidbrink, P. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.2.683-692.2004 · Cited by 323
Schwebke, J. R., Rompalo, A., Taylor, S., Sena, A. C., Martin, D. H., Lopez, L. M., Lensing, S., & Lee, J. Y. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq074 · Cited by 235
Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases
Jensen, J. S. (2004) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2004.00923.x · Cited by 225
Manhart, L. E., Gillespie, C. W., Lowens, M. S., Khosropour, C. M., Colombara, D. V., Golden, M. R., Hakhu, N. R., Thomas, K. K., Hughes, J. P., Jensen, N. L., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis1022 · Cited by 203
Azithromycin Failure in Mycoplasma genitalium Urethritis
Bradshaw, C. S., Jensen, J. S., Tabrizi, S. N., Read, T. R. H., Garland, S. M., Hopkins, C. A., Moss, L. M., & Fairley, C. K. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1207.051558 · Cited by 168
Fluoroquinolone and Macrolide Resistance-Associated Mutations in Mycoplasma genitalium
Tagg, K. A., Jeoffreys, N. J., Couldwell, D. L., Donald, J. A., & Gilbert, G. L. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00495-13 · Cited by 159
Research works printed but not linked: 3
- 2010, MMWR RECOMM REPORTS, 59, 1
- 2013, 4, e61481
- 2013, STIS, 89, A29
Cited by
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
2016 European guideline on Mycoplasma genitalium infections
Jensen, J. S., Cusini, M., Gomberg, M., & Moi, H. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13849 · Cited by 343
Machalek, D. A., Tao, Y., Shilling, H., Jensen, J. S., Unemo, M., Murray, G., Chow, E. P. F., Low, N., Garland, S. M., Vodstrcil, L. A., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30154-7 · Cited by 273
2021 European guideline on the management of Mycoplasma genitalium infections
Jensen, J. S., Cusini, M., Gomberg, M., Moi, H., Wilson, J., & Unemo, M. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17972 · Cited by 255
Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium
Unemo, M., & Jensen, J. S. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2016.268 · Cited by 233
Chlamydia trachomatis Genital Infections
O’Connell, C. M., & Ferone, M. E. (2016) · Microbial Cell · doi:10.15698/mic2016.09.525 · Cited by 213
Bissessor, M., Tabrizi, S. N., Twin, J., Abdo, H., Fairley, C. K., Chen, M. Y., Vodstrcil, L. A., Jensen, J. S., Hocking, J. S., Garland, S. M., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu1162 · Cited by 195
2016 European guideline on the management of non-gonococcal urethritis
Horner, P. J., Blee, K., Falk, L., van der Meijden, W., & Moi, H. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462416648585 · Cited by 190
Soni, S., Horner, P., Rayment, M., Pinto-Sander, N., Naous, N., Parkhouse, A., Bancroft, D., Patterson, C., & Fifer, H. (2019) · International Journal of STD & AIDS · doi:10.1177/0956462419825948 · Cited by 180
Getman, D., Jiang, A., O'Donnell, M., & Cohen, S. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01053-16 · Cited by 170
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
Murray, G. L., Bradshaw, C. S., Bissessor, M., Danielewski, J., Garland, S. M., Jensen, J. S., Fairley, C. K., & Tabrizi, S. N. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2305.161745 · Cited by 159
Mycoplasma genitalium: A Review
Gnanadurai, R., & Fifer, H. (2019) · Microbiology · doi:10.1099/mic.0.000830 · Cited by 153
Salado-Rasmussen, K., & Jensen, J. S. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu217 · Cited by 152
Management of Mycoplasma genitalium infections – can we hit a moving target?
Jensen, J. S., & Bradshaw, C. S. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1041-6 · Cited by 145
New Horizons in Mycoplasma genitalium Treatment
Bradshaw, C. S., Jensen, J. S., & Waites, K. B. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix132 · Cited by 122
Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan
Kikuchi, M., Ito, S., Yasuda, M., Tsuchiya, T., Hatazaki, K., Takanashi, M., Ezaki, T., & Deguchi, T. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku164 · Cited by 107
Touati, A., Peuchant, O., Jensen, J. S., Bébéar, C., & Pereyre, S. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03318-13 · Cited by 103
Chlamydia trachomatisand Genital Mycoplasmas: Pathogens with an Impact on Human Reproductive Health
Ljubin-Šternak, S., & Meštrović, T. (2014) · Journal of Pathogens · doi:10.1155/2014/183167 · Cited by 100
Guschin, A., Ryzhikh, P., Rumyantseva, T., Gomberg, M., & Unemo, M. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0781-7 · Cited by 97
Efficacy of Antimicrobial Therapy forMycoplasma genitaliumInfections
Manhart, L. E., Jensen, J. S., Bradshaw, C. S., Golden, M. R., & Martin, D. H. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ785 · Cited by 90
Lin, L., Yuan, K., Liang, X., Chen, X., Zhao, Z., Yang, Y., Zou, S., Luan, T., & Chen, B. (2015) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2015.08.036 · Cited by 85
Korenromp, E. L., Wi, T., Resch, S., Stover, J., & Broutet, N. J. N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170773 · Cited by 80
2016 United Kingdom national guideline on the sexual health care of men who have sex with men
Clutterbuck, D., Asboe, D., Barber, T., Emerson, C., Field, N. M., Gibson, S., Hughes, G., Jones, R., Murchie, M., Nori, A., et al. (2018) · International Journal of STD & AIDS · doi:10.1177/0956462417746897 · Cited by 79
Self-citationBarberá, M.-J., Fernández-Huerta, M., Jensen, J.-S., Caballero, E., & Andreu, A. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000631 · Cited by 78
Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment
Gaydos, C. A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix104 · Cited by 78
Time to eradication ofMycoplasma genitaliumafter antibiotic treatment in men and women
Falk, L., Enger, M., & Jensen, J. S. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv246 · Cited by 74
Nijhuis, R. H. T., Severs, T. T., der Vegt, D. S. J. M. V., van Zwet, A. A., & Kusters, J. G. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv136 · Cited by 74
Berçot, B., Charreau, I., Rousseau, C., Delaugerre, C., Chidiac, C., Pialoux, G., Capitant, C., Bourgeois‐Nicolaos, N., Raffi, F., Pereyre, S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1832 · Cited by 73
Mycoplasma genitalium infections: current treatment options and resistance issues
Sethi, S. K., Zaman, K., & Jain, N. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s105469 · Cited by 71
Mycoplasma genitalium and antimicrobial resistance in Europe: a comprehensive review
Fernández-Huerta, M., Barberà, M. J., Serra-Pladevall, J., Esperalba, J., Martínez‐Gómez, X., Centeno, C., Pich, Ò. Q., Pumarola, T., & Espasa, M. (2020) · International Journal of STD & AIDS · doi:10.1177/0956462419890737 · Cited by 70
Chua, T.-P., Vodstrcil, L. A., Murray, G. L., Plummer, E. L., Jensen, J. S., Unemo, M., Chow, E. P. F., Low, N. N., Whiley, D. M., Sweeney, E. L., et al. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2024.101047 · Cited by 69
Pereyre, S., Laurier‐Nadalié, C., Bébéar, C., Arfeuille, C., Beby‐Defaux, A., Berçot, B., Boisset, S., Bourgeois, N., Carles, M.-J., Decré, D., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.10.028 · Cited by 68
Mycoplasma genitalium in Toronto, Ont: Estimates of prevalence and macrolide resistance.
Gesink, D., Racey, C. S., Seah, C., Zittermann, S. I., Mitterni, L., Juzkiw, J., Jamieson, H., Greer, J., Singh, S., Jensen, J. S., et al. (2016) · Europe PMC (PubMed Central) · Cited by 65
Li, Y., Su, X., Le, W., Li, S., Yang, Z., Chaisson, C. E., Madico, G. E., Gong, X., Reed, G. W., Wang, B., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz294 · Cited by 65
Lewis, D. A., & Couldwell, D. L. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s48813 · Cited by 64
Fluoroquinolone-ResistantMycoplasma genitalium,Southwestern France
Roy, C. L., Hénin, N., Pereyre, S., & Bébéar, C. (2016) · Emerging infectious diseases · doi:10.3201/eid2209.160446 · Cited by 60
Dumke, R., Thürmer, A., & Jacobs, E. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.07.005 · Cited by 50
Shipitsyna, E. V., Rumyantseva, T., Golparian, D., Khayrullina, G., Lagos, A. C., Edelstein, I. A., Jõers, K., Jensen, J. S., Savicheva, A. M., Руднева, Н. С., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175763 · Cited by 49
Identification of macrolide‐resistant Mycoplasma genitalium using real‐time PCR
Wold, C., Sorthe, J., Hartgill, U., Olsen, A. O., Moghaddam, A., & Reinton, N. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12963 · Cited by 48
Background review for the 2016 European guideline on Mycoplasma genitalium infections
Jensen, J. S., Cusini, M., Gomberg, M. A., & Moi, H. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13850 · Cited by 47
Sadiq, S. T., Mazzaferri, F., & Unemo, M. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-053072 · Cited by 47
Self-citationRoy, C. L., Pereyre, S., Hénin, N., & Bébéar, C. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00579-17 · Cited by 46
Asenjo, A., Kusters, J. G., Severs, T. T., & Alós, J.-I. (2017) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2017.01.006 · Cited by 45
Fernández‐Rivas, G., Martró, E., González, V., Saludes, V., Bascuñana, E., Marcó, C., Rivaya, B., López-Corbeto, E., Coll, P., Matas, L., et al. (2015) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2015.10.014 · Cited by 45
Lower Urinary Tract Inflammation and Infection: Key Microbiological and Immunological Aspects
Dickson, K., Zhou, J., & Lehmann, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020315 · Cited by 44
Molecular basis of antimicrobial resistance in Mycoplasma genitalium
van der Schalk, T. E., Braam, J. F., & Kusters, J. G. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105911 · Cited by 42
Drug Resistance–Associated Mutations inMycoplasma genitaliumin Female Sex Workers, Japan
Deguchi, T., Yasuda, M., Horie, K., Seike, K., Kikuchi, M., Mizutani, K., Tsuchiya, T., Yokoi, S., Nakano, M., & Hoshina, S. (2015) · Emerging infectious diseases · doi:10.3201/eid2106.142013 · Cited by 41
Adesiyan, I. M., Bisi-Johnson, M. A., Ogunfowokan, A. O., & Okoh, A. I. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.02.062 · Cited by 40
Pitt, R., Fifer, H., Woodford, N., & Alexander, S. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2017-053164 · Cited by 40
Ke, W., Li, D., Tso, L. S., Wei, R., Lan, Y., Chen, Z., Zhang, X., Wang, L., Liang, C., Liao, Y., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05659-3 · Cited by 39
Françoise Van Bambeke, A. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.935470 · Cited by 38
Kristiansen, G. Q., Lisby, J. G., & Schønning, K. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00012-16 · Cited by 38
Multidrug-resistant Mycoplasma genitalium infections in Europe
Braam, J. F., van Dommelen, L., Henquet, C. J. M., van de Bovenkamp, J. H. B., & Kusters, J. G. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2969-9 · Cited by 37
Müller, E. E., Mahlangu, M. P., Lewis, D. A., & Kularatne, R. S. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3797-6 · Cited by 37
Smieszek, T., & White, P. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149087 · Cited by 36
Braam, J. F., Slotboom, B., van Marm, S., Severs, T. T., van Maarseveen, N. M., van Zwet, T., Boel, E. C. H., Berkhout, H., Hagen, F., van de Bovenkamp, J. H. B., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw584 · Cited by 36
Xiao, L., Waites, K. B., Pol, B. J. V. D., Aaron, K. J., Hook, E. W., & Geisler, W. M. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000891 · Cited by 35
de Jong, A., Rahamat-Langendoen, J. C., van Alphen, P., Hilt, N., van Herk, C., Pont, S., Melchers, W., & van de Bovenkamp, J. (2015) · International Journal of STD & AIDS · doi:10.1177/0956462415596496 · Cited by 35
Mycoplasma genitalium macrolide resistance in Stockholm, Sweden
Björnelius, E., Magnusson, C., & Jensen, J. S. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052688 · Cited by 34
Molecular Tools for Typing Mycoplasma pneumoniae and Mycoplasma genitalium
Dumke, R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.904494 · Cited by 34
Diagnosis and antimicrobial treatment ofMycoplasma genitaliuminfection: sobering thoughts
TAYLOR‐ROBINSON, D. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.919220 · Cited by 34
Hokynar, K., Hiltunen‐Back, E., Mannonen, L., & Puolakkainen, M. H. (2018) · International Journal of STD & AIDS · doi:10.1177/0956462418764482 · Cited by 34
Streeck, H., Jansen, K., Crowell, T. A., Esber, A. L., Jessen, H. K., Cordes, C., Scholten, S., Schneeweiss, S., Brockmeyer, N., Spinner, C. D., et al. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.14.2100591 · Cited by 33
Romano, S. S., Jensen, J. S., Lowens, M. S., Morgan, J. L., Chambers, L. C., Robinson, T. S., Totten, P. A., Soge, O. O., Golden, M. R., & Manhart, L. E. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy843 · Cited by 33
Fernández-Huerta, M., Serra-Pladevall, J., Esperalba, J., MORENO, A. J., Fernández‐Naval, C., Barberá, M.-J., Aparicio, D., Pich, Ò. Q., Pumarola, T., Jensen, J. S., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01886-19 · Cited by 31
Chernesky, M., Jang, D., Martín, I., Hoang, L., Naidu, P., Levett, P. N., Wylie, J., Rebbapragada, A., Ratnam, S., Smieja, M., et al. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000617 · Cited by 31
Antimicrobial resistance in Mycoplasma genitalium sampled from the British general population
Pitt, R., Unemo, M., Sonnenberg, P., Alexander, S., Beddows, S. A., Cole, M. J., Clifton, S., Mercer, C. H., Johnson, A. M., ISON, C. A., et al. (2020) · Sexually Transmitted Infections · doi:10.1136/sextrans-2019-054129 · Cited by 31
Scheffer, M. P., González‐González, L., Seybert, A., Ratera, M., Kunz, M., Valpuesta, J., Fita, I., Querol, E., Piñol, J., Martín‐Benito, J., et al. (2017) · Molecular Microbiology · doi:10.1111/mmi.13743 · Cited by 30
Gossé, M., Lysvand, H., Pukstad, B. S., & Nordbø, S. A. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01233-16 · Cited by 29
Day, M. J., Cole, M. J., Fifer, H., Woodford, N., & Pitt, R. (2021) · Sexually Transmitted Infections · doi:10.1136/sextrans-2020-054897 · Cited by 29
Guiraud, J., Helary, M., Roy, C. L., Elguero, É., Pereyre, S., & Bébéar, C. (2022) · Microorganisms · doi:10.3390/microorganisms10081587 · Cited by 28
Napierala, M., Munson, E. L., Wenten, D., Phipps, P., Gremminger, R., Schuknecht, M. K., Munson, K. L., Boyd, V., Hamer, D., Schell, R. F., et al. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.03.016 · Cited by 28
Ring, A., Balakrishna, S., Imkamp, F., Burkard, S., Triet, F., Brunschweiler, F., Grube, C., Bodmer, R., Kouyos, R. D., Günthard, H. F., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac217 · Cited by 27
Trent, M., Coleman, J. S., Hardick, J. P., Perin, J., Tabacco, L., Huettner, S., Ronda, J. C., Felter-Wernsdorfer, R., & Gaydos, C. A. (2018) · Sexually Transmitted Infections · doi:10.1136/sextrans-2017-053367 · Cited by 27
Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011–2015
Hadad, R., Golparian, D., Lagos, A. C., Ljungberg, J., Nilsson, P., Jensen, J. S., Fredlund, H., & Unemo, M. (2017) · Apmis · doi:10.1111/apm.12792 · Cited by 26
Aboud, S. S., Buhalata, S. N., Onduru, O. G., Chiduo, M. G., Kwesigabo, G., Mshana, S. E., Manjurano, A. M., Temu, M. M., Kishamawe, C., & Changalucha, J. M. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8010062 · Cited by 24
Mulligan, V., Lynagh, Y., Clarke, S., Unemo, M., & Crowley, B. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000940 · Cited by 24
Hart, T., Tang, W., Mansoor, S. A., Chio, M. T., & Barkham, T. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05019-1 · Cited by 24
Laumen, J., van Alphen, L. B., Maduna, L. D., Hoffman, C. M., Klausner, J. D., Medina‐Marino, A., Kock, M. M., & Peters, R. P. H. (2020) · Sexually Transmitted Infections · doi:10.1136/sextrans-2019-054371 · Cited by 24
Libois, A., Hallin, M., Crucitti, T., Delforge, M., & Wit, S. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196217 · Cited by 23
Fuller, S., Pacho, A., Broad, C., Nori, A., Harding-Esch, E. M., & Sadiq, S. T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215380 · Cited by 22
Self-citationNogueira, W. G., Jaiswal, A. K., Tiwari, S., Ramos, R. T. J., Ghosh, P., Barh, D., Azevedo, V., & Soares, S. D. C. (2021) · Genomics · doi:10.1016/j.ygeno.2021.06.011 · Cited by 22
Understanding the spread of de novo and transmitted macrolide-resistance in Mycoplasma genitalium
Cadosch, D., García, V., Jensen, J. S., Low, N. N., & Althaus, C. L. (2020) · PeerJ · doi:10.7717/peerj.8913 · Cited by 21
Gardnerella vaginalis and Mollicute detection in rectal swabs from men who have sex with men
Cox, C., Watt, A. P., McKenna, J. P., & Coyle, P. V. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462416665060 · Cited by 20
Braam, J. F., van Marm, S., Severs, T. T., Belousov, Y. S., Mahoney, W. C., & Kusters, J. G. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3350-3 · Cited by 20
Munson, E. L., Morgan, E., Sienkiewicz, L., Thomas, Y., Buehler, K., Ryan, D. T., Clifford, A., & Mustanski, B. S. (2020) · Sexually Transmitted Infections · doi:10.1136/sextrans-2020-054463 · Cited by 19
Mondeja, B., Couri, J., Preval, N. M. R., Blanco, O., Fernández, C., & Jensen, J. S. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3523-9 · Cited by 19
Harrison, M. A., Harding-Esch, E. M., Marks, M., Pond, M. J., Butcher, R., Solomon, A. W., Zhou, L., Tan, N. K., Nori, A., Kako, H., et al. (2019) · Sexually Transmitted Infections · doi:10.1136/sextrans-2018-053938 · Cited by 19
Self-citationPiñeiro, L., Idígoras, P., & Cilla, G. (2019) · Microorganisms · doi:10.3390/microorganisms7120609 · Cited by 19
Pond, M. J., Nori, A., Patel, S. A., Laing, K. G., Ajayi, M., Copas, A. J., Butcher, P. D., Hay, P., & Sadiq, S. T. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2014-051761 · Cited by 18
Self-citationConway, R. J. H., Cook, S., Malone, C. S., Bone, S. M., Hassan-Ibrahim, M. O., & Soni, S. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001095 · Cited by 17
Broad, C., Furegato, M., Harrison, M. A., Pond, M. J., Tan, N. K., Okala, S., Fuller, S., Harding-Esch, E. M., & Sadiq, S. T. (2020) · Sexually Transmitted Infections · doi:10.1136/sextrans-2019-054356 · Cited by 16
Self-citationSweeney, E. L., Tickner, J. A., Bletchly, C., Nimmo, G. R., & Whiley, D. M. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00641-20 · Cited by 14
Manhart, L. E. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu224 · Cited by 14
Gossé, M., Nordbø, S. A., & Pukstad, B. S. (2016) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2016/8382469 · Cited by 13
Sarıer, M., Sepin, N., Emek, M., Germen, A. T., Hoşcan, M. B., Konuk, E. Y., & Turgut, H. B. (2022) · Andrologia · doi:10.1111/and.14377 · Cited by 12
de Campos, L. J., Seleem, M. A., Feng, J., de Oliveira, K. M. P., dos Santos, J. V. D. A., Hayer, S. S., Clayton, J. B., Kathi, S., Fisher, D. J., Ouellette, S. P., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01894 · Cited by 12
Ali, S., Ali, S., Javed, S. O., Shoukat, S., Ahmad, S., Ali, S. S., Hussain, Z., Waseem, M., Rizwan, M., Suleman, M., et al. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104771 · Cited by 12
Mycoplasma genitalium: the next sexually transmitted superbug?
Hughes, G., & Saunders, J. (2018) · BMJ · doi:10.1136/bmj.k4376 · Cited by 12
Lam, P. P. H., Nguyen, N. H., Nguyen, T. T. T., Trinh, N. B., & Luong, B. A. (2024) · Infezioni in Medicina · doi:10.53854/liim-3202-10 · Cited by 11
Metadata
- Authors
- Pond, M. J., Nori, A. V., Witney, A. A., Lopeman, R. C., Butcher, P. D., & Sadiq, S. T.
- Affiliations
- St George's, University of London (GB)
- Corresponding author
- Pond, M. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-11-26
- Volume
- 58
- Issue
- 5
- Pages
- 631-637
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC3922211
- OpenAlex
- W2167772364
- Cited by
- 184
- References
- 31
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 7 · 2023: 6 · 2022: 10 · 2021: 15 · 2020: 23 · 2019: 20 · 2018: 16 · 2017: 20 · 2016: 22 · 2015: 14 · 2014: 13
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Clinical Infectious Diseases (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- Mycoplasma genitalium, non-gonococcal urethritis, macrolide resistance, fluoroquinolone resistance, Chlamydia trachomatis, gyrA, gyrB, parC, 23S rRNA, empirical antibiotic therapy, men, prevalence, genetic diversity
- MeSH terms
- Anti-Bacterial Agents, DNA, Bacterial, DNA, Ribosomal, Humans, Male, Mycoplasma Infections, RNA, Ribosomal, 23S, Urethritis, Genetic Variation, Prevalence, Macrolides, Polymorphism, Single Nucleotide, Fluoroquinolones, Drug Resistance, Bacterial, DNA Gyrase, DNA Topoisomerase IV, Mycoplasma genitalium, Multilocus Sequence Typing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.